Stocks to Consider. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other ...
The general mood among these heavyweight investors is divided, with 70% leaning bullish and 20% bearish. Among these notable ...
Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...
EDT Regeneron (REGN) down 3% after appeals court decision in Amgen (AMGN) patent fightLight Up your Portfolio with Spark:Easily identify ...
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
With what analysts are calling "strong" data, Amgen plans to file a regulatory submission for Uplizna, currently approved for ...
Most organizations have some type of multi-functional committee set up to evaluate generative AI applications. Those ...
Most organizations have some type of multifunctional committee set up to evaluate generative AI applications. Those ...
Dow Jones member Verizon is climbing despite the overall market correction. Amgen's weight loss drug is helping it to outperform the broad market. The NASDAQ opened more than 2% lower on Monday ...
Amgen (AMGN) is a biotech company based in California. It specializes in developing treatments for cardiovascular conditions, ...
The three most widely followed U.S. indexes ended in red last week. The S&P 500, the Dow Jones Industrial Average and the Nasdaq Composite slid 1.36%, 0.90% and 0.84%, respectively. The aggressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback